Case study: How Merck & Co. ensures patient and product safety
Committed to improving health and well-being around the world, from developing new therapies that treat and prevent disease to helping people in need, Merck & Co. recognizes that when people take its medicines and vaccines, they must have confidence in their efficacy and safety.
Abstract
Merck & Co. assesses the safety of its products in rigorous clinical trials Tweet This! before they are approved, committed to the timely registration of clinical trial information and disclosure of trial results – regardless of the outcome. After measuring and setting targets, Merck & Co. took action to ensure monitoring and compliance as well as risk management for all products, rigorously study products and work with regulators and healthcare professionals to characterize their safety profile, communicate about product risks and, also, identify, evaluate and report adverse experiences occurring in association with the use of its products.
Using the GRI Standards in order to maintain and increase the value of your company
With each publication in this series the FBRH team will highlight one key impact identified by a company reporting in accordance with the GRI Standards and show how it has taken a structured, systematic approach to improving performance. With such positive action companies build trust, by dealing responsibly and conscientiously with their impact on the environment and on their stakeholders (e.g. clients, suppliers, shareholders, local communities, NGOs or local government). Stakeholders that can hold it back or stop it from reaching its objectives
By building trust your company creates loyalty and long-term commitment to its services and brands
